Cancer Diagnoses Equipment
-
based in POLAND
Colorectal cancer (CRC) is the second-most common cancer diagnosed in women and third-most in men. Based upon five-year survival rates, chances of becoming cured remain to be approximately 65%. Therapies targeting immunological checkpoints, or more specifically their inhibition, promise effective treatment options for patients with ...
-
Manufactured by Curasightbased in DENMARK
Curasight has developed a novel and innovative Theranostics platform for improved cancer diagnose and treatment. The combination of using targeted radionuclide therapy to treat cancer, and a non-invasive PET imaging for diagnosing and monitoring, is known as Theranostics (Therapy + Diagnostics = Theranostics). Curasight’s ...
-
Manufactured by Genolution Inc.based in SOUTH KOREA
Reagent to extract DNA to diagnose cancer or tissues stored in ...
-
Manufactured by Focal Healthcarebased in CANADA
Prostate cancer is the only solid cancer still diagnosed through random sampling. Get accurate and meaningful results faster with a targeted approach. Thoughtfully engineered, the semi-robotic arm of the Fusion Bx allows you to effortlessly maneuver the probe to accurately locate and target suspicious regions of interest. An unrestricted ...
-
Manufactured by Carbon Medical Technologies, Inc.based in USA
Breast Tissue Markers used in conjunction with Breast Biopsy. Many medical conditions, including all cases of cancer, must be diagnosed by removing a sample of tissue from the patient and sending it to a pathologist for examination. This procedure is called a biopsy. ...
-
Manufactured by MiraDxbased in USA
Radiation therapy is a form of cancer treatment that is used in over 2/3 of cancer patients diagnosed every year. Although generally, radiation is a safe treatment, 5-10% of patients will experience serious side effects from treatment. In addition, some patients respond not only locally to radiation, but also have an immune response that can ...
-
Manufactured by Dutch Diagnostics BVbased in NETHERLANDS
The BT test is one of our newer Rapid Tests. Bladder Tumor or Cancer needs to be diagnosed as quickly as possible in order for treatment to be effective. The BT cassette test is an immunochromatographic rapid test for the qualitative detection of bladder cancer antigen (hcfHrp) in human urine. The test is intended to help to detect a ...
-
by Natera, Inc.based in USA
Signatera is a personalized, tumor-informed assay optimized to detect circulating tumor DNA (ctDNA) for molecular residual disease (MRD) assessment and recurrence monitoring for patients previously diagnosed with cancer, with broad utility for cancer ...
-
Manufactured by Triopsy Medical, Inc.based in USA
Our disruptive and innovative technology is addressing a significant and unmet need - that is, to diagnose cancer more accurately and earlier. We are targeting a well-defined market opportunity with accessible channels of distribution and are pursuing a streamlined 510(k) regulatory pathway with go-to-market strategy planned for ...
-
Manufactured by Salofa Oybased in FINLAND
The FOB test (Faecal Occult Blood Test) is a rapid test of blood in the stool. The FOB test measures the condition of the gastrointestinal tract by detecting haemoglobin in the blood of a stool sample. The test is suitable for detecting intestinal bleeding and helps, for example, in diagnosing colorectal cancer. The test package ...
-
based in GERMANY
Cancer is among the leading causes of death worldwide. Approximately 38 % of men and women will be diagnosed with cancer at some point during their lifetimes (based on 2013 – 2015 data1). Cancer can occur in any organ and in any cell type and the variability in clinical presentation makes early diagnosis difficult. ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you